S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Trading Channel Breakout in Lululemon Brought by Earnings
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Salesforce: Time to Snap it Up as the Market Buys the Dip?
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Trading Channel Breakout in Lululemon Brought by Earnings
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Salesforce: Time to Snap it Up as the Market Buys the Dip?
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Trading Channel Breakout in Lululemon Brought by Earnings
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Salesforce: Time to Snap it Up as the Market Buys the Dip?
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
What Should Investors Make of These 3 Dividend Cuts?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Trading Channel Breakout in Lululemon Brought by Earnings
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Constellation Brands Taps into Growth: Analysts Bullish on Stock
Salesforce: Time to Snap it Up as the Market Buys the Dip?
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
NASDAQ:ABCM

Abcam (ABCM) Stock Forecast, Price & News

$16.90
+0.65 (+4.00%)
(As of 06/2/2023 ET)
Compare
Today's Range
$16.31
$17.05
50-Day Range
$12.62
$17.90
52-Week Range
$12.48
$18.38
Volume
1.34 million shs
Average Volume
994,829 shs
Market Capitalization
$3.87 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00

Abcam MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
36.1% Upside
$23.00 Price Target
Short Interest
Healthy
0.26% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.26mentions of Abcam in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
26.83%
From $0.41 to $0.52 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

189th out of 983 stocks

Biological Products, Except Diagnostic Industry

23rd out of 164 stocks


ABCM stock logo

About Abcam (NASDAQ:ABCM) Stock

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Receive ABCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

ABCM Stock News Headlines

Abcam (NASDAQ:ABCM) Sees Strong Trading Volume
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Abcam plc (NASDAQ:ABCM) Short Interest Update
SVB Securities Keeps Their Buy Rating on Abcam (ABCM)
Abcam, plc Business Update
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Abcam (NASDAQ:ABCM) Reaches New 12-Month High at $17.76
Abcam (NASDAQ:ABCM) Sees Unusually-High Trading Volume
Short Interest in Abcam plc (NASDAQ:ABCM) Declines By 25.4%
Abcam (ABCM) Shares Cross Above 200 DMA
Abcam Becomes Oversold (ABCM)
See More Headlines

ABCM Price History

ABCM Company Calendar

Today
6/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ABCM
Fax
N/A
Employees
1,760
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$23.00
High Stock Price Forecast
$23.00
Low Stock Price Forecast
$23.00
Forecasted Upside/Downside
+36.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$447.49 million
Cash Flow
$0.62 per share
Book Value
$3.92 per share

Miscellaneous

Free Float
213,842,000
Market Cap
$3.87 billion
Optionable
Not Optionable
Beta
0.64

Key Executives

  • Mr. Alan Thomas Hirzel BS (Age 55)
    M.B.A., M.S., MBA, MS, CEO & Exec. Director
    Comp: $1.49M
  • Mr. Michael Shaun Baldock B.A. (Age 59)
    CFO & Director
    Comp: $1.06M
  • Mr. Mark Dermody
    Interim CIO
  • James Staveley
    VP of Investor Relations
  • Marc Perkins
    Gen. Counsel & Company Sec.
  • Emma Sceats
    Sr. VP of Sales, Service & Bus. Devel.
  • Mr. Nick Skinner
    Sr. VP of HR
  • Mr. Mark Bushfield
    Sr. VP of Research & Innovation
  • Ms. Kirstie Speck BBusSc
    Head of Consumer Insights
  • Ms. Yvonne Chien
    Sr. VP of Customer Experience













ABCM Stock - Frequently Asked Questions

Should I buy or sell Abcam stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ABCM shares.
View ABCM analyst ratings
or view top-rated stocks.

What is Abcam's stock price forecast for 2023?

2 brokers have issued 12 month target prices for Abcam's shares. Their ABCM share price forecasts range from $23.00 to $23.00. On average, they predict the company's stock price to reach $23.00 in the next year. This suggests a possible upside of 36.1% from the stock's current price.
View analysts price targets for ABCM
or view top-rated stocks among Wall Street analysts.

How have ABCM shares performed in 2023?

Abcam's stock was trading at $15.56 at the beginning of 2023. Since then, ABCM shares have increased by 8.6% and is now trading at $16.90.
View the best growth stocks for 2023 here
.

Are investors shorting Abcam?

Abcam saw a decrease in short interest in May. As of May 15th, there was short interest totaling 603,500 shares, a decrease of 15.2% from the April 30th total of 711,400 shares. Based on an average daily trading volume, of 731,700 shares, the short-interest ratio is currently 0.8 days.
View Abcam's Short Interest
.

What ETFs hold Abcam's stock?
What guidance has Abcam issued on next quarter's earnings?

Abcam updated its first quarter 2023 earnings guidance on Monday, April, 17th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $121.46 million-$121.46 million.

When did Abcam IPO?

(ABCM) raised $149 million in an initial public offering (IPO) on Thursday, October 22nd 2020. The company issued 9,000,000 shares at $16.52 per share. Morgan Stanley, BofA Securities, SVB Leerink, Lazard and William Blair served as the underwriters for the IPO.

What is Abcam's stock symbol?

Abcam trades on the NASDAQ under the ticker symbol "ABCM."

Who are Abcam's major shareholders?

Abcam's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (6.76%), Wellington Management Group LLP (6.39%), Harding Loevner LP (5.99%), Baillie Gifford & Co. (5.20%), Brown Capital Management LLC (4.25%) and Wasatch Advisors LP (3.55%).

How do I buy shares of Abcam?

Shares of ABCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Abcam's stock price today?

One share of ABCM stock can currently be purchased for approximately $16.90.

How much money does Abcam make?

Abcam (NASDAQ:ABCM) has a market capitalization of $3.87 billion and generates $447.49 million in revenue each year.

How many employees does Abcam have?

The company employs 1,760 workers across the globe.

How can I contact Abcam?

The official website for the company is www.abcam.com. The company can be reached via phone at 44-0-12-2369-6000 or via email at investor.relations@abcam.com.

This page (NASDAQ:ABCM) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -